These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12592310)

  • 1. 19. Immunologic, gastroenterologic, and hepatobiliary disorders.
    James SP
    J Allergy Clin Immunol; 2003 Feb; 111(2 Suppl):S645-58. PubMed ID: 12592310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [1995 gastroenterology update--II].
    Layer P; Brambs HJ; Ell C; Fischbach W; Fleig WE; Schölmerich J; Zirngibl H
    Med Klin (Munich); 1996 Apr; 91 Suppl 1():81-8. PubMed ID: 8657091
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of gastrointestinal and hepatobiliary diseases.
    Galperin C; Gershwin ME
    JAMA; 1997 Dec; 278(22):1946-55. PubMed ID: 9396657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases].
    Spalinger J
    Schweiz Med Wochenschr Suppl; 2000; 122():17S-21S. PubMed ID: 12536465
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatobiliary complications of parenteral nutrition.
    Gaddipati K; Yang P
    Gastroenterologist; 1996 Jun; 4(2):98-106. PubMed ID: 8792140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary complications of inflammatory bowel disease.
    Bhutani MS; Rostami G; Gopalswamy N
    Am Fam Physician; 1995 Oct; 52(5):1440-4. PubMed ID: 7572566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.
    Saubermann LJ; Deneau M; Falcone RA; Murray KF; Ali S; Kohli R; Ekong UD; Valentino PL; Grossman AB; Rand EB; Jonas MM; Saeed SA; Kamath BM
    J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):639-652. PubMed ID: 27984347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatobiliary manifestations of inflammatory bowel disease.
    Harmatz A
    Med Clin North Am; 1994 Nov; 78(6):1387-98. PubMed ID: 7967915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmet challenges in immune-mediated hepatobiliary diseases.
    Beuers U; Gershwin ME
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):127-31. PubMed ID: 25820618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver and biliary tract involvement in rheumatic diseases].
    Peleshchuk AP; Lazar' AF; Svintsitskiĭ AS; Bul'da VI; Musienko LP; Fursova NIa; Nikula TD; Fedorich VN
    Vrach Delo; 1990 Oct; (10):27-30. PubMed ID: 2080572
    [No Abstract]   [Full Text] [Related]  

  • 12. IgG4-Related Disease of the Gastrointestinal Tract: A 21st Century Chameleon.
    Deshpande V
    Arch Pathol Lab Med; 2015 Jun; 139(6):742-9. PubMed ID: 26030243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatobiliary complications of idiopathic intestinal inflammations].
    Lukás M
    Cas Lek Cesk; 1997 Feb; 136(4):106-10. PubMed ID: 9221179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on therapy for hepatobiliary diseases.
    Kowdley KV
    Nurse Pract; 1996 Jul; 21(7):78, 81-4, 86. PubMed ID: 8823789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatobiliary manifestations in inflammatory bowel disease].
    Solís Herruzo JA; Solís-Muñoz P
    Rev Esp Enferm Dig; 2007 Sep; 99(9):525-42. PubMed ID: 18052648
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastrointestinal manifestations.
    Tanowitz HB; Simon D; Weiss LM; Noyer C; Coyle C; Wittner M
    Med Clin North Am; 1996 Nov; 80(6):1395-414. PubMed ID: 8941228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing HIV. Part 5: Treating secondary outcomes. 5.3 HIV, gastrointestinal and hepatobiliary disease.
    Sievert W; Shaw DR; Edwards P
    Med J Aust; 1996 Mar; 164(6):360-5. PubMed ID: 8606663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diet therapy in gastroenterologic diseases. Study from a critical viewpoint].
    Bircher J; Haemmerli UP
    Schweiz Med Wochenschr; 1967 Dec; 97(50):1687-96. PubMed ID: 5596895
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of gastrointestinal and hepatobiliary diseases in Thailand.
    Kullavanijaya P
    J Gastroenterol Hepatol; 1997 May; 12(5):S11-2. PubMed ID: 9195394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
    Grigor'eva GA; Meshalkina NIu
    Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.